EFM
E Fund Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Sell |
11,854
-1,121
| -9% | -$17.9K | 0.01% | 365 |
|
|
2025
Q1 | $222K | Buy |
12,975
+4,725
| +57% | +$80.8K | 0.01% | 349 |
|
|
2024
Q4 | $204K | Sell |
8,250
-1,539
| -16% | -$38.1K | 0.01% | 362 |
|
|
2024
Q3 | $279K | Buy |
9,789
+1,244
| +15% | +$35.5K | 0.01% | 272 |
|
|
2024
Q2 | $226K | Sell |
8,545
-5,130
| -38% | -$135K | 0.01% | 273 |
|
|
2024
Q1 | $442K | Buy |
13,675
+1,419
| +12% | +$45.8K | 0.03% | 180 |
|
|
2023
Q4 | $516K | Sell |
12,256
-2,989
| -20% | -$126K | 0.03% | 156 |
|
|
2023
Q3 | $585K | Buy |
15,245
+1,715
| +13% | +$65.8K | 0.04% | 111 |
|
|
2023
Q2 | $257K | Sell |
13,530
-5,093
| -27% | -$96.7K | 0.02% | 237 |
|
|
2023
Q1 | $289K | Buy |
18,623
+6,824
| +58% | +$106K | 0.02% | 232 |
|
|
2022
Q4 | $209K | Buy |
+11,799
| New | +$209K | 0.02% | 296 |
|
|
2021
Q4 | – | Sell |
-10,474
| Closed | -$91K | – | 306 |
|
|
2021
Q3 | $91K | Buy |
+10,474
| New | +$91K | ﹤0.01% | 261 |
|